Merck Bolsters Oncology Pipeline with $2.13 Billion SciBrunch Licensing Deal for KRAS G12D Inhibitor
In a significant move to reshape its oncology portfolio ahead of impending patent cliffs, Merck & Co. has secured exclusive...
oncology
Breakthrough in Oncology: Experimental Vaccine Shows Promise in Intercepting Pancreatic Cancer
In a landmark development for oncology, researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University have unveiled...
Precision Oncology’s New Frontier: The “Click-to-Assemble” Strategy Overcoming Drug Resistance
The landscape of cancer therapy has been fundamentally transformed by the advent of antibody-drug conjugates (ADCs)—potent, "guided-missile" pharmaceuticals designed to...
AstraZeneca Bolsters Oncology Franchise with $1.5 Billion Global Licensing Deal for Dizal’s Zegfrovy
In a major strategic maneuver that underscores the shifting landscape of global pharmaceutical partnerships, AstraZeneca has announced a definitive agreement...
Novartis Targets Oncology Leadership with $1.5B Acquisition of ADC Innovator Myricx Bio
In a significant move to reshape the future of precision oncology, pharmaceutical giant Novartis has announced a definitive agreement to...
GSK Bolsters Oncology Portfolio with $10.6 Billion Acquisition of Nuvalent
In a move that signals a significant shift in its long-term growth strategy, GlaxoSmithKline (GSK) has officially announced a definitive...
